Warby Parker Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | $0.110 |
| EPS actual | $0.120 |
| EPS Surprise | 9.09% |
| Revenue estimate | 239.437M |
| Revenue actual | 242.447M |
| Revenue Surprise | 1.26% |
| Release date | Feb 26, 2026 |
| EPS estimate | $0.0500 |
| EPS actual | -$0.0400 |
| EPS Surprise | -180.00% |
| Revenue estimate | 213.03M |
| Revenue actual | 211.968M |
| Revenue Surprise | -0.498% |
| Release date | Nov 06, 2025 |
| EPS estimate | $0.0900 |
| EPS actual | $0.110 |
| EPS Surprise | 22.22% |
| Revenue estimate | 213.108M |
| Revenue actual | 221.68M |
| Revenue Surprise | 4.02% |
| Release date | Aug 07, 2025 |
| EPS estimate | $0.0800 |
| EPS actual | $0.0800 |
| Revenue estimate | 222.89M |
| Revenue actual | 214.475M |
| Revenue Surprise | -3.78% |
Last 4 Quarters for Warby Parker
Below you can see how WRBY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 07, 2025 |
| Price on release | $23.48 |
| EPS estimate | $0.0800 |
| EPS actual | $0.0800 |
| Date | Price |
|---|---|
| Aug 01, 2025 | $23.60 |
| Aug 04, 2025 | $24.49 |
| Aug 05, 2025 | $24.35 |
| Aug 06, 2025 | $24.30 |
| Aug 07, 2025 | $23.48 |
| Aug 08, 2025 | $23.33 |
| Aug 11, 2025 | $23.22 |
| Aug 12, 2025 | $24.41 |
| Aug 13, 2025 | $26.81 |
| 4 days before | -0.508% |
| 4 days after | 14.18% |
| On release day | -0.639% |
| Change in period | 13.60% |
| Release date | Nov 06, 2025 |
| Price on release | $16.93 |
| EPS estimate | $0.0900 |
| EPS actual | $0.110 |
| EPS surprise | 22.22% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $19.59 |
| Nov 03, 2025 | $19.77 |
| Nov 04, 2025 | $19.65 |
| Nov 05, 2025 | $19.05 |
| Nov 06, 2025 | $16.93 |
| Nov 07, 2025 | $17.22 |
| Nov 10, 2025 | $17.40 |
| Nov 11, 2025 | $17.38 |
| Nov 12, 2025 | $17.49 |
| 4 days before | -13.58% |
| 4 days after | 3.31% |
| On release day | 1.71% |
| Change in period | -10.72% |
| Release date | Feb 26, 2026 |
| Price on release | $25.65 |
| EPS estimate | $0.0500 |
| EPS actual | -$0.0400 |
| EPS surprise | -180.00% |
| Date | Price |
|---|---|
| Feb 20, 2026 | $23.71 |
| Feb 23, 2026 | $22.20 |
| Feb 24, 2026 | $22.24 |
| Feb 25, 2026 | $21.77 |
| Feb 26, 2026 | $25.65 |
| Feb 27, 2026 | $25.01 |
| Mar 02, 2026 | $26.29 |
| Mar 03, 2026 | $27.48 |
| Mar 04, 2026 | $27.36 |
| 4 days before | 8.18% |
| 4 days after | 6.67% |
| On release day | -2.50% |
| Change in period | 15.39% |
| Release date | May 07, 2026 |
| Price on release | $27.20 |
| EPS estimate | $0.110 |
| EPS actual | $0.120 |
| EPS surprise | 9.09% |
| Date | Price |
|---|---|
| May 01, 2026 | $23.08 |
| May 04, 2026 | $21.99 |
| May 05, 2026 | $21.66 |
| May 06, 2026 | $22.03 |
| May 07, 2026 | $27.20 |
| May 08, 2026 | $29.55 |
| May 11, 2026 | $28.79 |
| May 12, 2026 | $26.95 |
| May 13, 2026 | $28.49 |
| 4 days before | 17.85% |
| 4 days after | 4.74% |
| On release day | 8.64% |
| Change in period | 23.44% |
Warby Parker Earnings Call Transcript Summary of Q1 2026
Warby Parker reported Q1 2026 revenue of $242.4M (up 8.3% YoY) and adjusted EBITDA of $29.6M (12.2% margin), beating guidance. Management reaffirmed full-year 2026 guidance: revenue $959M–$976M (≈10%–12% growth) and adjusted EBITDA $117M–$119M, and noted the guidance excludes any revenue from the planned AI glasses but does include pre- and post-launch investments. Key operational highlights: 14 net new stores opened in Q1 (50 targeted for 2026), exams grew ~30% YoY as exam services expanded to ~90% of stores, and e-commerce was down ~4% largely due to the lapping and sunset of the Home Try-On program (management expects this headwind to fade). Gross margin was pressured (adjusted gross margin 54.2%, down ~220 bps) from fixed cost deleverage (doctor headcount, occupancy), tariffs, and lab/shipping costs, but management expects tariff tailwinds and mix/operational improvements to help margins later in the year. Management is preparing for an AI (intelligent) eyewear launch later this year with partners Google and Samsung, investing in retail readiness, lab capacity, training and systems; the launch is expected to be transformational but is not included in near-term revenue guidance. Insurance penetration improved (in‑network ~10% penetration, up from ~8%), out-of-network reimbursement tooling rolled out and is driving higher AOVs, and the company is reallocating marketing toward higher-return channels and glasses (vs. contacts) while expanding channels like YouTube, TikTok and Reddit. Financial position remains solid with ~$288M cash, ~$8M free cash flow in Q1, and a $100M repurchase authorization; a $75M reimbursement from Google supports AI glasses investments. Overall, management emphasizes disciplined spend, confidence in underlying customer demand (particularly exams and higher-value frames/lenses), and that they are positioned to scale omnichannel distribution and capture share while launching AI eyewear later this year.
Sign In
Buy WRBY